Author Archive: Jim Lane

The Digest’s 2026 Multi-Slide Guide to Industrial AI Procurement Strategy

August 23, 2026 | Jim Lane

Most industrial AI pilots fail to reach production because operators mistakenly treat AI procurement as a software purchase rather than an architecture investment. AI cannot repair broken, fragmented data layers by inference alone; models require contextualized operating histories—including batch boundaries, lot genealogy, and equipment states—to generate value. To successfully deploy AI, companies must establish robust […]

The Digest’s 2026 Multi-Slide Guide to Lab-to-Plant Tech Transfer in Industrial Biology

August 16, 2026 | Jim Lane

Technology transfer is where industrial biology projects frequently lose money during the commercial ramp due to preventable operating failures. While written recipes transfer easily, critical “invisible cargo”—such as tacit operator knowledge, scale-dependent variables, and complex equipment interactions—is often left behind. To de-risk scale-up, developers must look past misleading calendar milestones. Instead, they should deploy joint […]

The Digest’s 2026 Multi-Slide Guide to RIN Market Dynamics

August 9, 2026 | Jim Lane

Producer economics are dictated by volatile RIN market prices rather than headline Renewable Volume Obligation (RVO) targets. Driven by feedstock costs, EV penetration, and surging biogas supplies, RIN price swings contribute more variance to producer P&L than any other policy variable. Because uncontracted merchant RINs are highly unbankable, volume growth cannot offset a price collapse. […]

The Digest’s 2026 Multi-Slide Guide to 45Z Tax Equity Structuring

August 2, 2026 | Jim Lane

While 45Z transferability offers new direct-sale routes, the credit still faces steep market discounts due to complex carbon-intensity diligence, evolving feedstock rules, and recapture risks. A transferable credit is fundamentally not cash, creating a monetization lag that threatens debt service if not properly bridged. Sponsors can avoid an 8 to 15 percent value loss by […]

The Digest’s 2026 Multi-Slide Guide to Standards Harmonization Fatigue

July 25, 2026 | Jim Lane

The bioeconomy is overwhelmed by overlapping standards, creating severe compliance fatigue that threatens market integrity. Operators face conflicting definitions and redundant audit requirements without clear hierarchy. This saturation forces rational “selective compliance,” where operators prioritize easier or buyer-mandated standards, eroding overall system rigor. Instead of creating marginal new standards or conducting uncoordinated consultations, the industry […]

The Digest’s 2026 Multi-Slide Guide to AI-Assisted MRV

July 18, 2026 | Jim Lane

While AI-assisted MRV crucially relieves verification capacity bottlenecks by automating evidence collection, mass-balance accounting, and LCA calculations, it outpaces current regulatory and liability frameworks. Current standards like ISO 14065 mandate that accredited human verifiers retain ultimate accountability, meaning AI reduces effort but not responsibility. Because liability allocation for AI errors remains unresolved and professional indemnity […]

The Digest’s 2026 Multi-Slide Guide to Sovereign-Backed Concessional Finance

July 10, 2026 | Jim Lane

Sovereign-backed concessional capital provides the patient, lower-cost funding essential for scaling first-of-a-kind bioeconomy plants. However, U.S. instruments like DOE LPO and USDA loans face strict mandates and lengthy approvals, lagging behind more flexible international green banks. This inflexibility creates a 100-to-250 basis point competitive disadvantage for domestic projects, turning capital cost into a critical site-selection […]

The Digest’s 2026 Multi-Slide Guide to Bio-Based Reverse Logistics

July 3, 2026 | Jim Lane

Bio-based product end-of-life claims—such as compostability or chemical recyclability—create significant legal and reputational liabilities when the required reverse logistics do not exist. Currently, fewer than ten percent of labeled products have accessible recovery infrastructure. To avoid greenwashing scrutiny and comply with expanding Extended Producer Responsibility (EPR) mandates, brands must stop relying on voluntary take-back models. […]

The Digest’s 2026 Multi-Slide Guide to Downstream Bioprocess Engineering

June 26, 2026 | Jim Lane

Bioeconomy diligence overwhelmingly focuses on upstream fermentation breakthroughs, masking the reality that downstream processing actually dictates commercial viability. Because downstream recovery accounts for most of a facility’s cost, under-engineering separation, chromatography, and crystallization leads to fatal economic surprises during scale-up. To prevent project failure, developers must partner with original equipment manufacturers to completely validate commercial-throughput […]

The Digest’s 2026 Multi-Slide Guide to Technology Performance Insurance

June 19, 2026 | Jim Lane

Traditional lenders refuse to underwrite the inherent engineering and execution risks of first-of-a-kind (FOAK) SAF projects. Technology Performance Insurance (TPI) solves this by converting unproven technology risks into bankable credit obligations backed by A-rated insurers. Because finite underwriting capacity is driving up premiums, developers must engage brokers early during EPC selection. Crucially, to successfully unlock […]

Free Subscription

The Biofuels Digest newsletter

The most widely-read biofuels daily — 20,000+ organizations subscribe — why not you too?